200 related articles for article (PubMed ID: 34080260)
1. Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer.
He DH; Chen YF; Zhou YL; Zhang SB; Hong M; Yu X; Wei SF; Fan XZ; Li SY; Wang Q; Lu Y; Liu YQ
Cancer Sci; 2021 Aug; 112(8):3218-3232. PubMed ID: 34080260
[TBL] [Abstract][Full Text] [Related]
2. Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis.
Xing S; Nong F; Wang Y; Huang D; Qin J; Chen YF; He DH; Wu PE; Huang H; Zhan R; Xu H; Liu YQ
Pharmacol Res; 2022 Feb; 176():106059. PubMed ID: 34998973
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
[TBL] [Abstract][Full Text] [Related]
4. Targeted Inhibition of the E3 Ligase SCF
Zhao H; Iqbal NJ; Sukrithan V; Nicholas C; Xue Y; Yu C; Locker J; Zou J; Schwartz EL; Zhu L
Cancer Res; 2020 Jun; 80(11):2355-2367. PubMed ID: 32265224
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics and chemical library screens reveal a novel SCF
Malek E; Abdel-Malek MA; Jagannathan S; Vad N; Karns R; Jegga AG; Broyl A; van Duin M; Sonneveld P; Cottini F; Anderson KC; Driscoll JJ
Leukemia; 2017 Mar; 31(3):645-653. PubMed ID: 27677741
[TBL] [Abstract][Full Text] [Related]
6. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
Su L; Han D; Wu J; Huo X
Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
[TBL] [Abstract][Full Text] [Related]
7. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
8. Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.
Chen Q; Xie W; Kuhn DJ; Voorhees PM; Lopez-Girona A; Mendy D; Corral LG; Krenitsky VP; Xu W; Moutouh-de Parseval L; Webb DR; Mercurio F; Nakayama KI; Nakayama K; Orlowski RZ
Blood; 2008 May; 111(9):4690-9. PubMed ID: 18305219
[TBL] [Abstract][Full Text] [Related]
9. Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors.
Liu YQ; Wang XL; Cheng X; Lu YZ; Wang GZ; Li XC; Zhang J; Wen ZS; Huang ZL; Gao QL; Yang LN; Cheng YX; Tao SC; Liu J; Zhou GB
Oncotarget; 2015 Oct; 6(33):34953-67. PubMed ID: 26474281
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.
Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X
J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337
[TBL] [Abstract][Full Text] [Related]
11. Ethanol Extract of Citrus grandis 'Tomentosa' Exerts Anticancer Effects by Targeting Skp2/p27 Pathway in Non-Small Cell Lung Cancer.
Huang D; Wu PE; Chen ZJ; Pang YC; Xu ZW; Tan J; Jiang ZH; Yang BB; Zhan R; Xu H; Liu YQ
Mol Nutr Food Res; 2023 Sep; 67(18):e2300061. PubMed ID: 37436082
[TBL] [Abstract][Full Text] [Related]
12. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
Hsu TI; Wang MC; Chen SY; Huang ST; Yeh YM; Su WC; Chang WC; Hung JJ
Mol Pharmacol; 2012 Dec; 82(6):1115-28. PubMed ID: 22956772
[TBL] [Abstract][Full Text] [Related]
13. [Betulinic acid inhibits non-small cell lung cancer by repolarizing tumor-associated macrophages via mTOR signaling pathway].
Zeng AQ; Chen X; Dai Y; Zhao JN
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2376-2384. PubMed ID: 38812138
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.
Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J
Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173
[TBL] [Abstract][Full Text] [Related]
15. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
[TBL] [Abstract][Full Text] [Related]
16. Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells.
Zhou H; Zhou L; Guan Q; Hou X; Wang C; Liu L; Wang J; Yu X; Li W; Liu H
Commun Biol; 2023 Aug; 6(1):805. PubMed ID: 37532777
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of the oncoprotein STAT3 as a target of a novel Skp1 inhibitor.
Cheng X; Liu YQ; Wang GZ; Yang LN; Lu YZ; Li XC; Zhou B; Qu LW; Wang XL; Cheng YX; Liu J; Tao SC; Zhou GB
Oncotarget; 2017 Jan; 8(2):2681-2693. PubMed ID: 27835873
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.
Chan CH; Morrow JK; Li CF; Gao Y; Jin G; Moten A; Stagg LJ; Ladbury JE; Cai Z; Xu D; Logothetis CJ; Hung MC; Zhang S; Lin HK
Cell; 2013 Aug; 154(3):556-68. PubMed ID: 23911321
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
[TBL] [Abstract][Full Text] [Related]
20. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
